Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Lucie Boyer"'
Autor:
Andréa Murru, Marie-Ève Allard, Guillaume Paré, Myriam Vaillancourt, Lucie Boyer, Marie-Pierre Cayer, Julien Vitry, Patricia Landry, Marie-Michèle Labrecque, Nancy Robitaille, Donald R. Branch, Mélissa Girard, Maria J. Fernandes
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Transfusion of granulocyte concentrates (GC) is an alternative therapy for neutropenic patients with life-threatening infections. While neutrophils are the main source of antimicrobial activity, only neutrophil numbers are used to certify GCs. The ob
Externí odkaz:
https://doaj.org/article/64946a23f12d41759a308264ba95c0a2
Autor:
Annie Maheux, Patrick Trépanier, Diane Fournier, Marc Cloutier, Éric Ducas, Lucie Boyer, Annie Jacques
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss S1, Pp S30-S30 (2019)
Externí odkaz:
https://doaj.org/article/aa8eb1db284b4e47b77cf69ca9d6138b
Autor:
François Labaste, Yoan Lavie-Badie, Robin Bouchau, Lucie Boyère, Pascale Sanchez-Verlaan, Hélène Gonzalez, Bertrand Marcheix, Roxana Botea, Fanny Vardon-Bounes, Vincent Minville
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionLow cardiac output syndrome (LCOS) is a common complication in cardiac surgery, and we evaluated the incidence of its early occurrence after mitral and tricuspid combined cardiac surgery and its associated risk factors.Material and method
Externí odkaz:
https://doaj.org/article/2d3619674bf9461b95f1043153d942d7
Autor:
Lucie Boyer, Marc Cloutier, Annie Maheux, Diane Fournier, Éric Ducas, Annie Jacques, Patrick Trépanier
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss S1, Pp S30-S30 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60643cc6053602242b66927e3cbca078
https://doi.org/10.1002/sctm.12578
https://doi.org/10.1002/sctm.12578
Autor:
Nicolas Pineault, Lucie Boyer
Publikováno v:
Transfusion. 51:72S-81S
BACKGROUND: Thrombocytopenia is a serious side effect following high-dose chemotherapy or whole-body irradiation. For many patients, a hematopoietic stem cell (HSC) transplant is required as part of the treatment or to restore the integrity of the he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1242889bbc477f6fb08c6a801a184740
https://doi.org/10.1111/j.1537-2995.2011.03369.x
https://doi.org/10.1111/j.1537-2995.2011.03369.x
Autor:
Alain Garnier, Nicolas Pineault, Cynthia Therien, Lucie Boyer, Denis-Claude Roy, Amélie Robert, Valérie Cortin
Publikováno v:
Cytotherapy. 13:467-480
Expansion of hematopoietic progenitors ex vivo is currently investigated as a means of reducing cytopenia following stem cell transplantation. The principal objective of this study was to develop a new cytokine cocktail that would maximize the expans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ce114c0e5004cf6a0f7cdb159244a4
https://doi.org/10.3109/14653249.2010.530651
https://doi.org/10.3109/14653249.2010.530651
Publikováno v:
Journal of Immunological Methods. 332:82-91
Expansion of hematopoietic progenitor cells (HPC) ex vivo remains an important focus in fundamental and clinical research. The aim of this study was to determine whether the implementation of such expansion phase in a two-phase culture strategy prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baad72e9382c7dc44dc927f8ded6fa7e
https://doi.org/10.1016/j.jim.2007.12.015
https://doi.org/10.1016/j.jim.2007.12.015
Publikováno v:
Experimental Hematology. 33:1182-1191
Objective A multi-step statistical strategy was applied to quantify individual and interactive effects of cytokines on megakaryopoiesis and to determine the concentration of the selected cytokines that optimize ex vivo megakaryocyte (MK) expansion, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171b9d264e42750542772d68b5cfdcb2
https://doi.org/10.1016/j.exphem.2005.06.020
https://doi.org/10.1016/j.exphem.2005.06.020
Publikováno v:
Blood. 99:1267-1272
The prophylaxis of the hemolytic disease of the newborn requires significant amounts of plasma-derived polyclonal human anti-D. Because of procurement problems, there is a growing interest in replacing plasma-derived anti-D by in vitro–produced hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2c3d9fb6d8a7f879d641e3738627f3
https://doi.org/10.1182/blood.v99.4.1267
https://doi.org/10.1182/blood.v99.4.1267
Publikováno v:
Transfusion. 42:59-65
BACKGROUND: In blood banks, D MoAbs are routinely used to phenotype donors and patients. However, most D MoAbs do not agglutinate RBCs that weakly express D. The use of higher affinity MoAbs could overcome this problem. In this work, an attempt has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a90b0729208c06a48296625217c3baef
https://doi.org/10.1046/j.1537-2995.2002.00006.x
https://doi.org/10.1046/j.1537-2995.2002.00006.x